Osteocalcin (OC), a vitamin K dependent calcium binding protein, is the only known bone-specific protein. It is a significant component of the extracellular matrix and circulating levels are widely used as a clinical marker of bone turnover. Osteocalcin synthesis and gene expression are modulated by numerous physiologic factors that are known to regulate osteoblast function, including steroid hormones. We have developed a normal diploid rat osteoblast culture system that produces a bone-like extracellular matrix to study regulation of OC within the complexity of changes that occur during extracellular matrix formation and mineralization. We have documented the differential expression and selective modification of osteocalcin by steroid hormones during the developmental sequence of osteoblast differentiation. We have cloned the rat OC gene, identified its vitamin D responsive element and a primary transcriptional regulatory element, both of which contain AP-1 sites that bind the oncogene encoded fos-jun proteins. It is known for other genes that transcription is regulated by interactions between independent elements as well as by multiple classes of transcription factors within a regulatory element. The synergistic and antagonistic effects of steroids on OC gene expression suggests that such regulatory mechanisms are operative. We propose to use normal diploid osteoblasts and a panel of chimeric gene constructs with deletions or targeted mutations in promoter regulatory elements to (1) define the levels and mechanisms at which regulation of osteocalcin gene transcription is mediated, both in vitro and in vivo (transgenic mice) in relation to tissue specificity bone development; (2) define physiologic mediators (vitamin D, glucocorticoid, estrogen) of OC gene transcription by characterizing the positive and negative promoter regulatory sequences, their cognate sequence-specific transcription factors, and the functional proximity of regulatory elements from chromatin structure studies; and (3) carry out functional studies by altering (by inhibition or premature upregulation) of OC expression. A systematic analysis of the OC promoter, focusing on positive and negative regulatory elements and steroid responsive elements that regulate OC gene transcription, we will make a contribution towards understanding its role in bone metabolism and, in a broad biological context, elucidate mechanisms associated with the regulation of genes by physiologic modulators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR033920-10
Application #
3156681
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1989-04-01
Project End
1996-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Hoffmann, H; Green, J; van Wijnen, A J et al. (2000) Expression screening of factors binding to the osteocalcin bone-specific promoter element OC box I: isolation of a novel osteoblast differentiation-specific factor. J Cell Biochem 80:156-68
Banerjee, C; McCabe, L R; Choi, J Y et al. (1997) Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 66:1-8
Frenkel, B; Capparelli, C; Van Auken, M et al. (1997) Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. Endocrinology 138:2109-16
Lian, J B; Shalhoub, V; Aslam, F et al. (1997) Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138:2117-27
Ryoo, H M; Hoffmann, H M; Beumer, T et al. (1997) Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11:1681-94
Banerjee, C; Stein, J L; Van Wijnen, A J et al. (1996) Transforming growth factor-beta 1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 137:1991-2000
McCabe, L R; Banerjee, C; Kundu, R et al. (1996) Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology 137:4398-408
Frenkel, B; Montecino, M; Green, J et al. (1996) Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain. Endocrinology 137:1080-88
Staal, A; Van Wijnen, A J; Desai, R K et al. (1996) Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 137:2001-11
Lian, J B; Stein, G S; Stein, J L et al. (1996) The osteocalcin gene promoter provides a molecular blueprint for regulatory mechanisms controlling bone tissue formation: role of transcription factors involved in development. Connect Tissue Res 35:15-21

Showing the most recent 10 out of 82 publications